Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence B Schwartz

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
The New England Journal of Medicine|June 6, 2008
Heparin comes cleanLawrence B Schwartz
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2005
Analysis of MC(T) and MC(TC) mast cells in tissueLawrence B Schwartz
Immunology and Allergy Clinics of North America|August 26, 2006
Diagnostic value of tryptase in anaphylaxis and mastocytosisLawrence B Schwartz
Clinical Allergy and Immunology|October 2, 2001
Mast cells and basophilsLawrence B Schwartz
Novartis Foundation Symposium|March 18, 2004
Effector cells of anaphylaxis: mast cells and basophilsLawrence B Schwartz
Biochemistry|August 18, 2004
Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitorsYoshihiro Fukuoka, Lawrence B Schwartz
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptasePhillip Lieberman, Lawrence B Schwartz
International Immunopharmacology|November 28, 2007
Active monomers of human beta-tryptase have expanded substrate specificitiesYoshihiro Fukuoka, Lawrence B Schwartz
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pHYoshihiro Fukuoka, Lawrence B Schwartz
The Journal of Allergy and Clinical Immunology|March 14, 2009
Assessing anaphylactic risk? Consider mast cell clonalityDean D Metcalfe, Lawrence B Schwartz
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|June 6, 2008
Heparin comes cleanLawrence B Schwartz
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2005
Analysis of MC(T) and MC(TC) mast cells in tissueLawrence B Schwartz
Immunology and Allergy Clinics of North America|August 26, 2006
Diagnostic value of tryptase in anaphylaxis and mastocytosisLawrence B Schwartz
Clinical Allergy and Immunology|October 2, 2001
Mast cells and basophilsLawrence B Schwartz
Novartis Foundation Symposium|March 18, 2004
Effector cells of anaphylaxis: mast cells and basophilsLawrence B Schwartz
Biochemistry|August 18, 2004
Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitorsYoshihiro Fukuoka, Lawrence B Schwartz
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Anaphylactic reaction to white-faced hornet sting and elevated baseline (asymptomatic) serum tryptasePhillip Lieberman, Lawrence B Schwartz
International Immunopharmacology|November 28, 2007
Active monomers of human beta-tryptase have expanded substrate specificitiesYoshihiro Fukuoka, Lawrence B Schwartz
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
The B12 anti-tryptase monoclonal antibody disrupts the tetrameric structure of heparin-stabilized beta-tryptase to form monomers that are inactive at neutral pH and active at acidic pHYoshihiro Fukuoka, Lawrence B Schwartz
The Journal of Allergy and Clinical Immunology|March 14, 2009
Assessing anaphylactic risk? Consider mast cell clonalityDean D Metcalfe, Lawrence B Schwartz
Pageof 12